318 related articles for article (PubMed ID: 19110198)
1. Multifunctional actions of approved and candidate stroke drugs.
Minnerup J; Schäbitz WR
Neurotherapeutics; 2009 Jan; 6(1):43-52. PubMed ID: 19110198
[TBL] [Abstract][Full Text] [Related]
2. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
[TBL] [Abstract][Full Text] [Related]
3. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
Adams RJ; Albers G; Alberts MJ; Benavente O; Furie K; Goldstein LB; Gorelick P; Halperin J; Harbaugh R; Johnston SC; Katzan I; Kelly-Hayes M; Kenton EJ; Marks M; Sacco RL; Schwamm LH; ;
Stroke; 2008 May; 39(5):1647-52. PubMed ID: 18322260
[No Abstract] [Full Text] [Related]
4. Combination antiplatelet agents for secondary prevention of ischemic stroke.
Vande Griend JP; Saseen JJ
Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
[TBL] [Abstract][Full Text] [Related]
5. [Antithrombotic therapy in ischemic stroke and transient ischemic attack].
Overgaard K; Poulsen TS; Husted SE
Ugeskr Laeger; 2007 Oct; 169(40):3379-82. PubMed ID: 17953858
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of ex vivo high on-treatment platelet reactivity on antiplatelet therapy after transient ischemic attack or ischemic stroke on the PFA-100(®) and VerifyNow(®).
Kinsella JA; Tobin WO; Cox D; Coughlan T; Collins R; O'Neill D; Murphy RP; McCabe DJ
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e84-92. PubMed ID: 22981273
[TBL] [Abstract][Full Text] [Related]
7. What's new in stroke? The top 10 studies of 2006-2008. Part I.
Hart RG
Pol Arch Med Wewn; 2008 Nov; 118(11):650-7. PubMed ID: 19140569
[TBL] [Abstract][Full Text] [Related]
8. Aspirin and clopidogrel for prevention of ischemic stroke.
Thomson RM; Anderson DC
Curr Neurol Neurosci Rep; 2013 Feb; 13(2):327. PubMed ID: 23299823
[TBL] [Abstract][Full Text] [Related]
9. Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial.
Bath PM; Appleton JP; Beridze M; Christensen H; Dineen RA; Duley L; England TJ; Heptinstall S; James M; Krishnan K; Markus HS; Pocock S; Ranta A; Robinson TG; Flaherty K; Scutt P; Venables GS; Woodhouse LJ; Sprigg N
Int J Stroke; 2017 Jul; 12(5):524-538. PubMed ID: 27811309
[TBL] [Abstract][Full Text] [Related]
10. A benefit-risk assessment of agents used in the secondary prevention of stroke.
MacWalter RS; Shirley CP
Drug Saf; 2002; 25(13):943-63. PubMed ID: 12381215
[TBL] [Abstract][Full Text] [Related]
11. Aspirin should be first-line antiplatelet therapy in the secondary prevention of stroke.
Warlow C
Stroke; 2002 Aug; 33(8):2137-8. PubMed ID: 12154276
[No Abstract] [Full Text] [Related]
12. Antiplatelet agents for secondary prevention of ischemic stroke.
Majid A; Delanty N; Kantor J
Ann Pharmacother; 2001 Oct; 35(10):1241-7. PubMed ID: 11675854
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of previous antiplatelet drug use in patients with new or recurrent ischemic stroke: Buffalo metropolitan area and Erie County stroke study.
Qureshi AI; Kirmani JF; Safdar A; Ahmed S; Sayed MA; Pande RU; Ferguson R; Hershey LA; Qazi KJ
Pharmacotherapy; 2006 Apr; 26(4):493-8. PubMed ID: 16553507
[TBL] [Abstract][Full Text] [Related]
14. Newer antiplatelet therapies in stroke prevention.
Davis SM; Donnan GA
Aust Fam Physician; 2001 Feb; 30(2):129-34. PubMed ID: 11280112
[TBL] [Abstract][Full Text] [Related]
15. [Secondary prevention with clopidogrel after TIA or stroke].
Zuurbier SM; Vermeer SE; Hilkens PH; Algra A; Roos YB
Ned Tijdschr Geneeskd; 2013; 157(25):A5836. PubMed ID: 23777963
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet therapy to prevent recurrent stroke: Three good options.
Mansoor AH; Mujtaba MT; Silver B
Cleve Clin J Med; 2013 Dec; 80(12):787-95. PubMed ID: 24307163
[TBL] [Abstract][Full Text] [Related]
17. [Antithrombotic treatment as primary and secondary prevention of stroke].
Chukanova EI; Chukanova AS; Nadareyshvili GG; Gulieva MS
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(10):85-88. PubMed ID: 28635860
[TBL] [Abstract][Full Text] [Related]
18. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
Jamieson DG; Parekh A; Ezekowitz MD
J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet treatment in ischemic stroke treatment.
Pinto A; Di Raimondo D; Tuttolomondo A; Di Sciacca R; Arnao V; La Placa S; Milio G; Miceli S; Licata G
Curr Top Med Chem; 2009; 9(14):1298-316. PubMed ID: 19849660
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antiplatelet agents for secondary prevention of stroke using mixed treatment comparison meta-analysis.
Malloy RJ; Kanaan AO; Silva MA; Donovan JL
Clin Ther; 2013 Oct; 35(10):1490-1500.e7. PubMed ID: 24139421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
